📑 Drug-resistant infections have reached a tipping point. Without urgent action, #AMR deaths could rise by 70% by 2050.

We need innovation and access to the right antibiotics. 🌍

🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...

A Communications Medicine publication proposes a comprehensive One Health stewardship framework to address AMR. CARB-X and Global Antibiotic R&D Partnership (GARDP) are recognized as important push incentives supporting antibiotic R&D. #IDSky 🧪
🔗 Read here: bit.ly/3KSyMvh

Antibiotic resistance is serious—but awareness is the first step to change. Share your story in Voices Against Resistance this #WAAW2025 & help protect antibiotics for the future.
buff.ly/yYbcDkP
Hear Mara's Story: youtube.com/shorts/Axf_B...

@who.int’s new report shows the antibacterial R&D pipeline is shrinking — just 90 candidates remain in development, with limited innovation against critical pathogens.

Strengthening both discovery and access is key to tackling AMR.

🔗Read the report: www.who.int/publications...

#Fungalinfections are a silent global health crisis.
They kill more than TB or malaria and hit the most vulnerable hardest—TB, HIV, and cancer patients.

Drug resistance is rising. Few treatments exist.

🎧 Learn more in our podcast with GAFFI’s Dr. David Denning:
🔗 onehealthtrust.org/news-media/p...

'Nearly a third of consumed antibiotics end up in rivers.' A new modeling study highlights the potential threat that human antibiotic use may pose to global waterways.